Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fc receptors are a family of cell surface glycoproteins expressed primarily on immune effector cells (such as macrophages, neutrophils, NK cells, and some B cells) that bind the Fc region of immunoglobulin molecules (IgG, IgA, IgE, IgM, and IgD)[1][4][5]. Engagement of Fc receptors by antibody-bound targets connects humoral antibody recognition to diverse cellular immune responses, including phagocytosis, antibody-dependent cellular cytotoxicity (ADCC), release of inflammatory mediators, and modulation of cytokine signaling. Fc receptors are classified by the immunoglobulin isotype they bind and by structural/functional characteristics, with the principal groups being FcγRs (for IgG), FcαRs (for IgA), and FcεRs (for IgE)[1][4][5]. Key subtypes include FcγRI (CD64), FcγRII (CD32), and FcγRIII (CD16), among others. Genetic polymorphisms and variations in these receptors are linked to differences in immune response, susceptibility to autoimmune diseases, and the efficacy of antibody-based therapies[1][2][5]. Note: To extract a specific "canonical name," further specification of the subclass (e.g., Fc gamma receptor IIIa) is required. "Effector cell Fc receptor" is a general functional description, not a unique molecular target.
Mediates effector functions of therapeutic antibodies via IgG Fc region—promotes phagocytosis and ADCC by engaging immune cell FcγRs[1][6] Can inhibit or modulate immune response depending on activating vs. inhibitory receptor engaged (ITAM vs ITIM signaling motifs)[1][2][5]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fc receptor for immunoglobulin (FcR).